News Releases

June 17, 2014

RepliCel Life Sciences Announces Closing of Third and Final Tranche of Private Placement
VANCOUVER, BC – June 17, 2014 – RepliCel Life Sciences Inc. (“RepliCel” or the “Company”) (OTCQB: REPCF) (TSXV: RP), is pleased to announce it... Read full article

June 5, 2014

RepliCel Retains Christina Cameron as Canadian Investor Relations Consultant
VANCOUVER, BC – June 5, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF), today announced that it has retained Christina Cameron as... Read full article

May 21, 2014

RepliCel Life Sciences Inc. Announces Closing of Second Tranche of Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES VANCOUVER, BC – May 21, 2014 – RepliCel... Read full article

May 20, 2014

RepliCel Life Sciences’ Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance RCH-01, a Treatment for Pattern Baldness
VANCOUVER, BC – May 20, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) a clinical stage regenerative medicine company focused on the... Read full article

May 9, 2014

RepliCel Life Sciences Inc. Announces Closing of Brokered and Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES VANCOUVER, BC – May 9, 2014 – RepliCel... Read full article

March 28, 2014

RepliCel Life Sciences Announces Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC – March 28, 2014 – RepliCel... Read full article

March 18, 2014

RepliCel Reports 2013 Annual Financial Results
VANCOUVER, BC – March 18, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) a clinical stage regenerative medicine company focused on the... Read full article

February 27, 2014

RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine
VANCOUVER, BC – February 27, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) announced that its Director of Research and Development, Dr.... Read full article

February 26, 2014

RepliCel Retains Ubika Communication for Online Capital Market Exposure
VANCOUVER, BC – February 26, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF), today announced that it has retained Ubika Communication, a... Read full article

January 13, 2014

RepliCel Receives Japanese Patent Covering its Hair Regeneration Technology
VANCOUVER, BC – January 13, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) today announced that it has been granted a patent... Read full article